Dow Jumps 150 Points; Icosavax Shares Plunge

U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.

The Dow traded up 0.48% to 31,097 while the NASDAQ rose 0.13% to 11,196.51. The S&P also rose, gaining, 0.19% to 3,828.87.

Also check this: McCormick, General Mills And 3 Stocks To Watch Heading Into Wednesday


Leading and Lagging Sectors


Health care shares jumped by 1.3% on Wednesday. Meanwhile, top gainers in the sector included Hyperfine, Inc. HYPR, up 23% and Atara Biotherapeutics, Inc. ATRA up 14%.


In trading on Wednesday, energy shares fell by 2.3%.


Top Headline


US crude oil inventories dropped by 2.762 million barrels in the week ended June 24th, compared to a 0.386 million decline in the prior period, the EIA said.


Equities Trading UP


Trevi Therapeutics, Inc. TRVI shares shot up 22% to $2.47 after the company announced positive results from its Phase 2b/3 PRISM trial of Haduvio in treating prurigo nodularis, a chronic disease characterized by severe pruritus and the presence of nodules, lesions, and excoriations.


Shares of 2U, Inc. TWOU got a boost, shooting 17% to $10.90. Indian online education provider Byju’s offered to buy 2U for $15 a share in cash, valuing the edtech company at more than $1 billion, reported Bloomberg, citing a person familiar with the matter.


Allena Pharmaceuticals, Inc. ALNA shares were also up, gaining 155% to $0.3031 after the company announced it has terminated its previously announced at-the-market offering.


Equities Trading DOWN

Aspen Aerogels, Inc. ASPN shares tumbled 44% to $8.22 following news of a $225 million offering by the company. The offering follows news earlier in June of reduced 2022 bottom-line guidance by the Aspen Aerogels.


Shares of Agile Therapeutics, Inc. AGRX were down 34% to $1.5799. Agile Therapeutics filed for offering of up to 15.7 million shares.


Icosavax, Inc. ICVX was down, falling 25% to $6.28 after the company announced interim results from its Phase 1/1b clinical trial of IVX-121, respiratory syncytial virus (RSV) F antigen, in young and older adults.


Also check out: U.S. Stock Futures Edge Higher; GDP Report In Focus


Commodities

In commodity news, oil traded down 0.9% to $110.72, while gold traded down 0.1% to $1,820.00.


Silver traded down 0.4% to $20.72 on Wednesday while copper rose 0.1% to $3.7835.



Euro zone


European shares closed lower today. The eurozone’s STOXX 600 fell 0.67%, London’s FTSE 100 fell 0.15% while Spain’s IBEX 35 Index fell 1.56%. The German DAX dropped 1.73%, French CAC 40 fell 0.90% and Italy’s FTSE MIB Index fell 1.21%.

Retail sales in Spain rose by 1.4% year-over-year in May compared to revised 1.6% increase in the prior month, while annual inflation rate increased to 10.2% in June from 8.7% in May. Loans to households in the Eurozone increased 4.6% year-over-year in May.


Economics


The US economy contracted by an annualized rate of 1.6% on quarter in the first quarter, compared to a 1.5% decline in the second estimate. The country’s economy recorded the first contraction since the pandemic-induced recession in 2020.


Corporate profits in the US dropped 4.9% to $2.40 trillion in the first quarter.


US crude oil inventories dropped by 2.762 million barrels in the week ended June 24th, compared to a 0.386 million decline in the prior period, the EIA said.


Check out this: US GDP And Other Macro Issues For Wednesday


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 89,030,720 cases with around 1,041,350 deaths. India confirmed a total of at least 43,436,430 cases and 525,070 deaths, while Brazil reported over 32,207,080 COVID-19 cases with 670,900 deaths. In total, there were at least 550,871,330 cases of COVID-19 worldwide with more than 6,354,200 deaths.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!